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Abstract 
 
In this work, the role of shock-wave (SW)-induced increase of bone morphogenetic proteins 
(BMPs) in modulating the osteogenic properties of osteoblast-like cells seeded on a bioactive 
scaffold was investigated using gremlin as a BMP antagonist. Bone-like glass-ceramic scaffolds, 
based on a silicate experimental bioactive glass (CEL2) developed at the Politecnico di Torino, 
were produced by the sponge replication method and used as porous substrates for cell culture. 
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Human MG-63 cells, exposed to SWs and seeded on the scaffolds, were treated with gremlin every 
2 days and analysed after 20 days for the expression of osteoblast differentiation markers. SWs have 
been shown to induce osteogenic activity mediated by increased expression of alkaline phosphatase, 
osteocalcin, type I collagen, BMP-4 and BMP-7. Cells exposed to SWs plus gremlin showed 
increased growth in comparison with cells treated with SWs alone and, conversely, mRNA contents 
of alkaline phosphatase and osteocalcin were significantly lower. Therefore, the SW-mediated 
increased expression of BMPs in MG-63 cells seeded on the scaffolds is essential in improving 
osteogenic activity; blocking BMPs via gremlin completely prevents the increase of alkaline 
phosphatase and osteocalcin. The results confirmed that the combination of glass-ceramic scaffolds 
and SWs exposure could be used to significantly improve osteogenesis opening new perspectives 
for bone regenerative medicine. 
 
Keywords: Scaffold; Shock waves; Gremlin; BMPs; Bone tissue engineering. 
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Introduction  
 
Tissue engineering represents an interdisciplinary approach to regenerate damaged or diseased 
tissues through integration of cell biology and biomaterials science. The concept behind tissue 
engineering is to regenerate target tissue by mimicking the developmental or regenerative process 
of that tissue; therefore, such an approach can be considered an ideal therapeutic option for treating 
various tissue defects [1]. Tissue engineering of skin [2], cartilage [3] and bone [4] has already been 
shown both feasible and effective in several clinical studies, and its efficacy has attracted significant 
attention from patients, clinicians and biomaterials researchers. 
Patients who lose healthy bone tissue as a result of trauma, tumour or inflammation need bone 
regenerative/reconstructive surgery in order to recover the function of the lost bone. Transplant of 
an autologous bone graft is the current gold standard to regenerate the lost bone tissue, although this 
approach is a great burden for patients because autografts must be harvested from a healthy site 
with the need for extra-surgery and problems of donor site morbidity and pain [5]. Artificial bone 
substitutes of various origin have been proposed as alternatives to autologous bone [6-8], although 
bone regeneration with them still exhibit some limitations. For example porous polyethylene, that 
since the 1990s has been marketed with the commercial name of Medpor® and is widely used in 
cranio-maxillofacial reconstruction, allows fibrovascular invasion but newly-formed bone does not 
grow within the polymer porous network due to the lack of both osteo-conductive and osteo-
inductive properties [9]. Hydroxyapatite (HA) has been regarded as an ideal bone substitute 
material due to its chemical and crystallographic similarity with the mineral phase of bone tissue 
[10], but problems of implant brittleness were observed especially if it is produced in a porous form 
[11]. Bioactive glasses and glass-ceramics are promising in overcoming the above-mentioned 
limitations as they can have mechanical properties similar to those of healthy bone [12] and can 
tightly bond to the host bone creating a stable interface [13]. 
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The development of tissue engineered bioactive glass/cells constructs that could be actually suitable 
for in vivo bone repair is a complex issue requiring the exhaustive knowledge of the artificial 
materials involved as well as the fine mechanisms of cell osteogenetic activity. A fascinating and 
new topic of biomedical research aims to understand what stimuli can be provided to cells to 
promote osteogenesis and, more generally, hard tissue repair. In this regard, shock waves (SWs) are 
used to treat musculoskeletal disorders, thanks to their efficacy in favouring callus formation in 
long-bone fractures [14-17]. Despite considerable clinical results and some in vitro research, the 
exact mechanisms underlying SW effect on bone healing still remain unknown. Recently, 
extracorporeal SW treatment was found to be effective in promoting bone healing (79% success 
rate) in patients with long-bone non-unions: the effect was found to be associated with systemic 
elevation of serum NO levels and osteogenic growth factors, including TGF-β1, VEGF and bone 
morphogenetic protein (BMP)-2 [18]. These observation confirmed the results previously obtained 
in an animal models by the same research group [19]. In vitro studies on human osteoblast-like cells 
have shown that treatment with SWs influences cell proliferation, enhancing transmembrane 
currents, as well as the voltage dependence of Ca-activated and K channels [20]. Other studies 
suggested that exposure to extracorporeal SWs enhances meseoblast recruitment at the junction of 
ossified cartilage and the production of TGF-β1 and VEGF-A, which are chemotactic and 
mitogenic, for the recruitment and differentiation of mesenchymal stem cells to promote bone 
regeneration of segmental defects in rats [21]. More recently, a direct dose-dependent stimulatory 
effects of SWs on the proliferation and differentiation of osteoblasts from normal human cancellous 
bone was reported by Hofmann et al. [22]; microarray analysis showed that SW application 
determines an up-regulation of multiple genes involved in skeletal development and osteoblast 
differentiation (e.g., PTHrP, prostaglandin E2-receptor EP3, BMP-2 inducible kinase, chordin, 
cartilage oligomeric matrix protein, matrillin). 
Muzio et al. [23] recently demonstrated that SWs initially induce an increase of cell number and 
osteogenic activity in MG-63 human osteoblast-like cells colonizing bioactive glass scaffolds 
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(compared to cells untreated with SWs), whereas at a later stage they reduce the number of cells 
further increasing osteogenic activity, as evidenced by more numerous and larger calcium deposits 
observed in scaffolds colonized by SW-treated cells. In the same study, a direct effect of SWs on 
BMP expression was shown for the first time, as it was found that the osteoinductive effect of SWs 
was mediated by increased expression of ALP, osteocalcin, type I collagen, BMP-4, BMP-7 and 
BMP-2 [23]. 
In order to investigate the involvement of increased BMPs expression induced by SWs in 
modulating the osteogenic properties of human osteoblast-like cells, in this study MG-63 cells were 
exposed to SWs, seeded on a bioactive glass-ceramic scaffold and for the first time treated with 
gremlin. Gremlin is a secreted BMP antagonist that is well-known to be mainly involved in the 
initiation of osteoblast differentiation [24] In this research the effect of gremlin was examined only 
at 20 days since in our  previous study [23] the major differentiation of osteoblasts treated with SWs 
and seeded on the scaffold was present at this experimental time. This topic is interesting in view of 
the development of ever more effective strategies to treat bone diseases via the tissue engineering 
approach.  
 
Materials and methods 
 
Macroporous scaffolds 
 
Synthesis of the starting glass 
 
Foam-like macroporous scaffolds were produced using a 6-oxides silica-based experimental glass 
(CEL2; 45SiO2-3P2O5-26CaO-15Na2O-7MgO-4K2O mol.%) as a starting material. The glass was 
originally developed by Vitale-Brovarone and co-workers at the Politecnico di Torino for bone 
tissue engineering applications [25]. CEL2 reagents (high-purity powders of SiO2, Ca3(PO4)2, 
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CaCO3, Na2CO3, (MgCO3)4·Mg(OH)2·5H2O, K2CO3 purchased from Sigma-Aldrich) were molten 
in a platinum crucible at 1500 °C for 1 h in air; the melt was quenched in cold water to obtain a frit, 
that was subsequently ground by using a 6-balls zirconia milling jar and sieved (Giuliani stainless 
steel sieve) to obtain particles with size below 32 µm.  
 
Scaffolds fabrication 
 
The scaffolds were produced by the sponge replication method, that was shown to be very effective  
to obtain porous ceramics with a highly-interconnected 3-D network of open macropores [26]. 
Small cubic blocks (15.0 mm × 15.0 mm × 15.0 mm) of a commercial open-cells polyurethane (PU) 
sponge (density of the porous polymer ∼20 kg m-3) were coated with CEL2 powder by being 
impregnated in a water-based glass slurry (glass : distilled water : poly(vinyl alcohol) (PVA) = 30 : 
64 : 6 wt.%). After PVA hydrolysis under continuous magnetic stirring at 80 °C, CEL2 powder was 
added to the solution; the water evaporated during PVA dissolution was re-added to the slurry to 
restore the correct weight ratios among the components. After further stirring for 15 minutes at 
room temperature to ensure slurry homogeneity, the sponge blocks were immersed for 60 s in the 
slurry. The slurry infiltrated the porous network of the PU template that was extracted from the 
slurry and subsequently compressed (20 kPa for 1 s) up to 60% in thickness along three orthogonal 
spatial directions, in order to homogeneously remove the excess slurry. The samples were dried at 
room temperature overnight and afterwards thermally treated at 950 °C for 3 h (heating and cooling 
rates set at 5 and 10 °C min-1, respectively) in order to burn-off the polymeric template and to sinter 
the inorganic particles. As reported elsewhere [26], two crystalline silicate phases develop during 
the above-mentioned heat treatment; however, for the sake of simplicity, the expression “CEL2 
scaffold” will be hereafter adopted, without further specifying the glass-ceramic nature of the 
sintered material. 
 
 7 
Scaffold characterization 
 
The scaffolds were chromium-coated and their morphology and porous 3-D architecture were 
investigated by scanning electron microscopy (Philips 525M; accelerating voltage = 15 kV). The 
inner porous network was also non-destructively investigated by micro-computed tomography 
(micro-CT; SkyScan 1174, Micro Photonics Inc.) to assess the pores characteristics. For the sake of 
comparison, the total porosity of the scaffolds was also calculated through mass-volume 
measurements as ( ) 1001 0 ×− ρρ s , wherein ρs is the scaffold density (mass/volume ratio) and ρ0 (g 
cm-3) is the density of bulk material. 
 
Biological assessment 
 
Materials 
 
MEM medium, foetal bovine serum (FBS), and the other reagents were purchased from Sigma (St. 
Louis, MO, USA). Gremlin was purchased from R&D Systems (Minneapolis, MN, USA). 
 
Scaffold pre-treatment 
 
The scaffolds (dimensions: 10.0 mm × 10.0 mm × 10.0 mm due to the shrinkage occurring upon 
heat treatment) were soaked in Tris-buffered simulated body fluid (SBF) [27] for 1 week to 
stimulate the formation of a HA layer, which is known to act as a biomimetic skin favouring cell 
adhesion. Before seeding cells, the SBF-treated scaffolds were sterilized with ultraviolet light 
exposure and preconditioned for 24 h in multiwells containing culture medium. 
 
Cell culture conditions 
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Human osteoblast-like cell line, MG-63 (ATCC, Rockville, MD, USA), was grown in MEM 
medium containing 2 mM L-glutamine, 1% (v/v) antibiotic/antimycotic solution, 1 mM sodium 
pyruvate, and 10% (v/v) FBS in an atmosphere of 5% CO2 and 95% air at 37 °C. 
 
Treatment of cells with SWs 
 
The SW generator utilized was a piezoelectric device (Piezoson 100, Richard Wolf, Knittlingen, 
Germany) designed for clinical use in orthopaedics and traumatology. The instrument generates 
focused underwater SWs at various frequencies (1 to 4 impulses/s) and intensities (0.05 to 1.48 
mJ/mm2). For medical use in orthopaedics, SWs of approximately 0.01 to 0.6 mJ/mm2 are applied 
[28]. The experimental set-up has been described elsewhere [29]. Briefly, each cell-containing tube 
was placed vertically in the generator. The SW unit was held in contact with the tube by means of a 
water-filled cushion. Ultrasound gel was used as contact medium between cushion and tube. MG-63 
cells (106/ml) were exposed to SWs at an energy level corresponding to 0.22 mJ/mm2; 100 total 
impulses were used. 
 
Cell growth within scaffolds and gremlin treatment 
 
Cells were divided in the three experimental groups: 1) cells not exposed to SWs and not treated 
with gremlin (C); 2) cells exposed to SWs and not treated with gremlin (SW); 3) cells exposed to 
SWs and treated with gremlin (SW+G). For each experimental group, cells were seeded (90,000 
cells) on the scaffolds and analysed on day 20 of treatment. Gremlin (0.9 µg/ml dissolved in PBS) 
was added to the cells of group 3 on alternate days. At the appropriate times, scaffolds were treated 
with trypsin/EDTA (0.25%/0.3%) to harvest the cells grown within them. Detached cells were used 
for the following determinations. 
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Cell count and viability 
 
Cells were counted in a Burker chamber using a light microscope (Leitz, Wetzlar, HM-LUX, 
Germany). Viability was checked microscopically with the trypan blue exclusion test (dye 
concentration 0.8 mg/ml); 400 cells were counted for each sample and results were expressed as 
percentages of trypan blue-positive cells. 
 
Evaluation of osteoblast activity parameters 
 
After 20 days, cells detached from scaffolds of all experimental groups were examined for the 
assessment of osteoblast activity parameters. mRNA content of BMP-4, BMP-7, alkaline 
phosphatase (ALP), and osteocalcin (OCN) was determined by real-time PCR as reported elsewhere 
[23]. GAPDH was used as housekeeping gene. The sequences of forward and reverse primers are 
reported in Table 1. The fold change in mRNA content was defined as the relative expression 
compared to that of control cells, taken as 1, and calculated as (2 – ∆∆Ct), where ∆Ct = Ctsample - 
CtGAPDH and ∆∆Ct = ∆Ctsample - ∆Ctcontrol. 
 
Statistical analysis 
 
All data are expressed as means ± SD of 3 different experiments. The significance of differences 
between group means was assessed by variance analysis, followed by the Newman-Keuls test (p < 
0.05). 
 
Results 
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Glass-ceramic scaffolds 
 
Figure 1 shows the open-cells structure of a typical PU sponge, used as a sacrificial template for 
scaffolding, that exhibits a 3-D network of pores ranging from 200 up to 800 µm. The porosity of 
the PU foam, assessed by micro-CT measurements, was 90 vol.%; the mean strut thickness and the 
mean pore size were 84 µm and 580 µm, respectively. During the sponge replication process, the 
polymeric foam was coated with a thin and continuous layer of CEL2 particles in order to obtain, 
after the heat treatment, a glass-derived replica of the template (Figure 2). The total porosity of the 
scaffolds was estimated to be 69 vol.% by micro-CT analysis (Figure 3), that also revealed an 
excellent 3-D interconnectivity of the macropores (the open porosity was estimated to be above 
95% of the overall porosity). The mean strut thickness and mean pore size were 101 µm and 445 
µm, respectively; these values are comparable to those reported by other authors for human 
cancellous bone [30]. An extensive characterization of CEL2 scaffolds by micro-CT has been 
reported elsewhere by Renghini and co-workers [31,32]. Density assessment through mass-volume 
measurement substantially confirmed the assessments by micro-CT (total porosity of about 70 
vol.%). 
 
Biological tests 
 
Figure 4 shows the effect of gremlin on the growth of human MG-63 cells exposed to SWs before 
seeding on the scaffolds. The significant decrease in cell numbers observed in SW-treated cells (–
30%) in comparison with control cells was completely prevented by gremlin, which indeed 
somewhat increased cell numbers (+7%). Viability, evaluated by the trypan blue exclusion test, 
remained about 100% in all experimental groups (data not shown). 
Figures 5 and 6 show the mRNA content of BMP-4, BMP-7, ALP and OCN in control cells, and in 
SW-exposed cells treated or not with gremlin. Compared to control cells, with regard to BMP-4 
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expression (Figure 5(a)), an 8.5-fold increase was observed in SW-exposed cells, whereas this 
induction decreased significantly (by 3.9 times) in cells grown in the presence of gremlin. With 
regard to BMP-7 expression (Figure 5(b)), the mRNA increase was completely blocked in the 
gremlin-treated cells; the content doubled in SW-treated cells, whereas it was similar to that of 
control cells in the presence of gremlin. 
The effect of gremlin on ALP mRNA was similar to that on BMP-4 (Figure 6(a)). The increase due 
to SW exposure (4.6 times) was partially reduced by gremlin (1.7 times). In the case of OCN 
(Figure 6(b)) the effect of gremlin was more marked: the mRNA content of this osteogenic factor in 
cells exposed to SWs and maintained in the presence of BMP inhibitor was decreased in 
comparison with both SW-treated cells (–67%) and control cells ( –53%). 
 
Discussion 
 
The use of absorbable biomaterials is often desirable in bone and dental surgery, so that the implant 
can be progressively replaced by new tissue while dissolving over time [33-36]. However, if strong 
and safe mechanical support to surrounding tissues and/or external loads is a goal, implantation of 
an absorbable material could be risky. CEL2 formulation was properly designed so that the 
resulting scaffolds have a very moderate tendency to resorption in aqueous media [30] 
(maintenance of structural integrity after implantation [12,26]) and good bioactive properties 
(formation of a HA layer on scaffold struts, which is a precondition for the development of a tight 
bond to host bone [32]). Furthermore, CEL2 scaffolds closely mimicked the foam-like structure of 
cancellous bone and exhibited well-densified and sound trabeculae. The porosity content is in the 
range recommended for bone tissue engineering scaffolds [37]. The presence of an open, highly 
interconnected 3-D porous network (as assessed through micro-CT analysis) is a key feature for 
bone tissue engineering applications, as the flow of culture medium containing cells during cell 
seeding throughout the scaffold is critical to develop an evenly populated tissue engineered 
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construct and it is fundamental that there are paths for cells to migrate, tissue to grow in and waste 
products to flow out in vivo. 
An improved knowledge of the molecular mechanisms underlying the osteogenic properties of SWs 
could be important in order to expand their application in several medical fields, including 
orthopaedics and dental diseases characterized by marked bone loss. Muzio et al. reported 
elsewhere that the joint use of SWs and glass-ceramic macroporous scaffolds increases the activity 
of human osteoblast-like MG-63 cells, probably via increased expression of BMPs [23]. The 
present research confirms that SW-induced modulation of BMPs is a crucial event in improving 
osteogenic properties of MG-63 cells grown on scaffolds: in fact, the inhibition of the BMP activity 
by treatment with gremlin completely prevents the effects of SWs. 
With regard to effects on cell growth, SW-treated cells exposed to gremlin show an increased 
proliferation rate versus controls, which confirms our previous suggestion that the reduced cell 
proliferation caused by SWs corresponds to an induction of cell differentiation, coupled with 
increased osteogenic activity of MG-63 cells [23]. This inverse correlation between cell growth and 
tissue-specific activity of the cells is in agreement with recent reports by other research groups, 
showing that in osteoblastic cells the growth arrest is accompanied by an increase of bone formation 
[38]. 
The results of this study are also in accordance with the observations by Chang et al. [39], who 
showed that BMP-4 induces G0/G1 arrest and differentiation in osteoblast-like cells, by increasing 
expression of p21CIP and p27KIP1. These authors also evidenced a transient BMP-4-mediated 
increase in association of β3-integrin with focal adhesion kinase and in Shc/ErK2, contributing to 
the SMAD1/5 phosphorylation. The involvement of ERK in the osteoblast differentiation signalling 
cascade has been also demonstrated in C3H10T1/2 mesenchymal progenitor cells, following BMP-
2 inducement [40]. 
Figure 5 shows that the treatment with gremlin also decreased the expression of BMP-4 and BMP-
7. It is known that gremlin exerts its potent inhibitory action by binding to and forming 
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heterodimers with BMP-2, BMP-4, and BMP-7; the binding of gremlin to selective BMPs prevents 
ligand-receptor interaction and subsequent downstream signalling [41]. It may be hypothesized that 
this effect is the consequence either of the gremlin-induced block of differentiation due to SW 
exposure, or of decreased expression of BMPs due to the lack of binding between BMPs and their 
receptors. In the present study, the effects over a 20-day period of analysis were investigated 
consistently to the experimental protocol adopted elsewhere [23,25]; looking at the future, 
experiments to investigate the expression of BMPs at early phases of SW-gremlin treatment and to 
determine the signalling pathways involved will be important to draw more definite conclusions. 
The importance of increased BMP expression in mediating SW osteogenic properties is confirmed 
by the observation that, in gremlin-treated cells, the expression of both ALP and OCN is much 
lower than it is in SW-treated cells, and that the OCN value is below that of control cells. Some 
signalling transduction pathways activated by SWs and leading to the increased expression of 
BMPs can be postulated. Other authors reported elsewhere that SWs are able to induce ERK 
phosphorylation [42,43].  Interestingly, phosphorylated ERK1/2 by fluid shear stress mediates the 
expression of osteogenic genes via activation of BMPs/mothers against decapentaplegic (Smad) 
pathway acting through NF-κB and regulating Runx2 expression [44]. Finally, low-intensity pulsed 
ultrasounds affect phosphorylation of Smad transcription factors; phosphorylated Smads enter the 
nucleus and function as effectors of BMP signalling by regulating transcription of specific genes 
involved in osteogenic differentiation [45]. 
In addition, SWs could act as a physical stimulus at the plasma-membrane level, inducing changes 
in protein or lipid components and, as a consequence, modulating BMP transcription. If SWs have 
an effect on polyunsaturated fatty acid (PUFAs) of membrane phospholipids, this could modulate 
the amount of ligands available for peroxisome proliferator-activated receptors (PPARs); ligand-
activated transcription factors regulate several metabolic pathways, including osteogenesis. Future 
investigations to assess the amount of free PUFAs and the changes occurring to PPARs in SW-
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treated cells will be useful to clarify the possible importance of this metabolic pathway in increasing 
BMP expression. 
 
Conclusions and perspectives 
 
Glass-ceramic scaffolds mimicking the architectural characteristics of cancellous bone were 
successfully fabricated by the sponge replication technique and used as porous substrates for in 
vitro biological investigations using osteoblast-like cells. It was shown the direct and essential 
involvement of increased BMP expression in the osteogenic effect of SWs, thus improving current 
knowledge of the molecular mechanisms underlying the osteogenic properties of this type of 
physical stimulation on bone formation. Looking at future applications, it is worth underlining the 
clinical importance of having tissue engineered scaffolds with a high bone regenerative potential to 
be associated to BMP-mediated osteogenic stimulation due to SW exposure. This combination 
could be used as a promising alternative to loading implantable scaffolds with recombinant human 
BMPs, which would result in a significant reduction of medical costs. 
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Figure legends  
 
Figure 1. PU sponge used as a sacrificial template: (a) SEM micrograph (magnification 50×) and 
(b) micro-CT reconstruction of the porous polymer structure. 
 
Figure 2. CEL2 scaffold: (a) digital camera picture of the obtained cuboid after heat treatment (950 
°C/3 h) and (b) SEM micrograph of the interconnected porous architecture of the scaffold 
(magnification 300×). 
 
Figure 3. Micro-CT analysis of CEL2 scaffold: (a) 3-D reconstruction of a scaffold sub-volume 
(dimensions about 5 mm × 2 mm × 2 mm) and (b) mid-length cross-sections in the [xy], [xz] and 
[yz] orthogonal planes. 
 
Figure 4. Osteoblasts grown in scaffolds after exposure to SWs and treatment with gremlin. Data 
are expressed as mean ± SD of 3 different experiments. Means with different letters are 
significantly different from one another (p = 0.0064) as determined by analysis of variance followed 
by post-hoc Newman-Keuls test. Labels: C = control cells; SW = cells exposed to SWs; SW + G = 
cells exposed to SWs and treated with gremlin. 
 
Figure 5. mRNA content of BMP-4 and BMP-7 in osteoblasts grown in scaffolds after exposure to 
SWs and treatment with gremlin. Data are expressed as mean ± SD of 3 different experiments. For 
each panel, means with different letters are significantly different from one another (p < 0.05) as 
determined by analysis of variance followed by post-hoc Newman-Keuls test. Labels: C = control 
cells; SW = cells exposed to SWs; SW + G = cells exposed to SWs and treated with gremlin. 
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Figure 6. mRNA content of alkaline phosphatase (ALP) and osteocalcin (OCN) in osteoblasts 
grown in scaffolds after exposure to SWs and treatment with gremlin. Data are expressed as mean ± 
SD of 3 different experiments. For each panel, means with different letters are significantly 
different from one another (p < 0.05) as determined by analysis of variance followed by post-hoc 
Newman-Keuls test. Labels: C = control cells; SW = cells exposed to SWs; SW + G = cells exposed 
to SWs and treated with gremlin. 
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Table 1. Forward and reverse primer sequences for real-time PCR analysis. 
Gene 
Access Number 
Sequence 
FW: forward primer; RV: reverse primer 
Annealing 
(°C) 
Cycles 
GAPDH 
NM_002046 
FW-5’-GTC GGA GTC AAC GGA TTT GG-3’ 
RV-5’-GGG TGG AAT CAT ATT GGA ACA TG-3’ 
52 
 
30 
ALP 
NM_000478 
FW-5’-CTC CCA GTC TCA TCT CCT-3’ 
RV–5’-AAG ACC TCA ACT CCC CTG AA-3’ 
58 
 
40 
Osteocalcin 
NM_199173 
FW-5’-GTG ACG AGT TGG CTG ACC-3’ 
RV–5’-CAA GGG GAA GAG GAA AGA AGG-3’ 
59 
 
35 
BMP-7 
NM_001719 
FW-5’-GTG GAA CAT GAC AAG GAA T-3’ 
RV-5’-GAA AGA TCA AAC CGG AAC-3’ 
58 
 
40 
BMP-4 
D30751 
FW-5’-CTC GCT CTA TGT GGA CTT C-3’ 
RV-5’-ATG GTT GGT TGA GTT GAG G-3’ 
58 
 
45 
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